A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Tudor Pop
Jenna Brashear
Omar Beirat
| Share Statistics | RPRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $26,974.9 | $618.0 | 89% |
|
| Shares Out (Mil) | 556.9 | 44.8 | 90% |
|
| Institutional Ownership | 93.1% | 85.3% | 63% |
|
| Float (Mil) | 415.4 | 47.4 | 84% |
|
| Beta | na | 0.70 | na |
|
| Avg Daily Volume (000s) | 2,969 | 390 | 87% |
|
| Price Change (52-week) |
68.3% | 68.6% | 85% |
|
| Growth | RPRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.3% | 6.7% | 24% |
|
| Net Income (5yr) | (4.6%) | (1.6%) | 34% |
|
| EPS (5yr) | 6.2% | 14.9% | 40 |
|
| Dividends (5yr) | 24.0% | 0.0% | 77% |
|
| Cash Flow (5yr) | (18.7%) | (14.9%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | $1.171 | $5.330 | $5.737 | |
| Month Ago EPS | $1.130 | $5.228 | $5.592 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $1.130 | $5.117 | $5.614 | |
| Year/Year Chg | 2,828% | 199.3% | 262.8% | |
| Financials | RPRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,536 | $291 | 64% |
|
| Net Income (TTM) (Mil) | $812 | ($11) | 84% |
|
| EPS (TTM) | $1.864 | ($0.700) | 70% |
|
| Operating Cash Flow (TTM) (Mil) | $2,977 | ($6) | 91% |
|
| Net Cash Flow (TTM) (Mil) | $180 | $5 | 83% |
|
| Long-Term Debt (Q1) (Mil) | $8,582 | $6 | 90% |
|
| Enterprise Value (Q1) (Mil) | na | $450 | na |
|
| Valuation | RPRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.95 | 2.78 | 72% |
|
| P/E | 32.5 | 17.4 | 72% |
|
| Dividend Yield | 1.6% | 0.0% | 73% |
|
| PEG (5yr hist) | 5.2 | 1.1 | 88% |
|
| Ratios | RPRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 95.8% | 67.0% | 95% |
|
| Net Margin | 32.0% | (2.3%) | 90% |
|
| ROA | 4.3% | (22.4%) | 68% |
|
| ROE | 12.3% | (20.2%) | 64% |
|
| Liabilities to Assets | 50.6% | 32.2% | 43% |
|
| F-Score | 5 | 3 | 50% |
|
Royalty Pharma plc did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
